हिन्दी
English
मराठी
বাংলা
தமிழ்
മലയാളം
ગુજરાતી
తెలుగు
ಕನ್ನಡ
ଓଡ଼ିଶା
Business
Tech
World
Health
NEWS
VIDEOS
PHOTOS
Web Stories
LIVE TV
GO
Latest
India
Ahmedabad
Bengaluru
Chennai
Hyderabad
Kolkata
Mumbai
Pune
Cricket
Success Story
Entertainment
Hollywood
Music
Bollywood
Television
Regional
Movie Review
Lifestyle
Relationship
Travel
Food & Recipes
Fashion
Culture
Spirituality
Business
Economy
Markets
Companies
Real Estate
International Business
Personal Finance
Automobile
Technology
Gadgets
Gaming
Internet & Social Media
Apps
Mobiles
World
Asia
Africa
Americas
Australia-Oceania
Europe
Auto
Mobility
Viral
Diabytes
Fables of Facades
Archived Videos
Newsletter
Fables of Facades
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Latest
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Advertisement
X
News
approval
Approval News
Abortion law
27 Oct 2022
Finland eases abortion by reforming outdated law - Here's how
Lawmakers approve the Legislative reform that will ease the process of getting an abortion in Finland This Nordic region has the strictest abortion law Now, this country will abolish the need for approval from two doctors to terminate a pregnancy
corona vaccine
01 Jan 2021
Corona vaccine's dry run across the country tomorrow
The government is gearing up against Coronavirus. In this connection, a dry run of Corona vaccine will be done across the country tomorrow.
Doha Bank
01 Dec 2014
Doha Bank shareholders approve India assets buy
Shareholders of Doha Bankhave approved the purchase of the Indian assets of HSBC Bank Oman after an extraordinary meeting, the Qatari bank said in a statement on Monday.
Cox & Kings
21 Nov 2014
Cox & Kings fixes QIP floor price at Rs 309.18
Tours and travel firm Cox & Kings has fixed the floor price at Rs 309.18 per equity share for raising funds through the qualified institutional placement (QIP) route to mop up Rs 1,200 crore.
Ranbaxy
19 Nov 2014
Ranbaxy shares slump 5% mcap down Rs 1,072 crore
Shares of Ranbaxy Laboratories slumped nearly 5 percent today as the company sued USFDA over revoking an approval to sell generic versions of two drugs -- digestive disorder medicine Nexium and anti-viral Valcyte-- in the US market.
137937
1
1
Loading...
Trending news
DNA Video
DNA: Scuffle Over Article 370 in Jammu & Kashmir Assembly: Why Was Abdullah Smiling?
DNA Video
DNA: Secret Strategy Revealed Ahead of Maharashtra Elections?
DNA Video
DNA: What is Bhagwa-e-Hind?
DNA Video
DNA: Trump-Modi Friendship: Pakistan’s Worries Grow
DNA Video
DNA: Trump’s Victory: What Changes Are Coming?
DNA Video
DNA: Yogi’s Bulldozer Politics in Maharashtra
DNA Video
DNA: Article 370 - CM Abdullah’s Gamble Falls Short?
DNA Video
DNA: Supreme Court Upholds Validity of UP Madrasa Act
DNA Video
DNA: US Presidential Elections and its Global Implications
DNA Video
DNA: Yogi Adityanath’s Winning Formula for Upcoming Elections!
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
×
Cookies Settings
Reject
Accept Cookies
NEWS ON ONE CLICK